NUVB
Nuvation Bio Inc. · Healthcare · Market cap $1.7B
Insiders sold $2.0M net in the last 90 days ·4 sellers, 1 buyer· 4 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 21, 2026
Insider Buying
$118K
reported purchases (SEC code P)
Insider Selling
$9.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Aug 21, 2026
Hattersley Gary
Nuvation Bio Inc. (NUVB) has 17 SEC Form 4 filings (40 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 21, 2026.
Inside the rolling window, 7 insiders at Nuvation Bio Inc. reported 1 open-market purchase totaling $118K and 16 open-market sales totaling $9.7M. The most active filer is CHIEF MEDICAL OFFICER Liu Dongfang with 7 filings. Insiders have net sold $3.3M over the trailing 6 months. The most recent open-market filing is a sale of 100,000 shares by CHIEF SCIENTIFIC OFFICER Hattersley Gary, dated Aug 19, 2026, worth $709K.
- Industry:Biotechnology
- CEO:David T. Hung
- Employees:305
- HQ:New York City, NY, US
- IPO:2020-08-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
Hattersley GaryFirst in 9 months | CHIEF SCIENTIFIC OFFICER | Sale | 100,000 | $709K | Aug 21 | -30.0% | SEC ↗ |
Markel StacyFirst filing | CHIEF PEOPLE OFFICER | Sale | 125,000 | $753K | Jun 24 | -24.9% | SEC ↗ |
| CHIEF REGULATORY OFFICER | Sale | 63,000 | $379K | Jun 24 | -24.9% | SEC ↗ | |
Sauvage PhilippeFirst filing | Chief Financial Officer | Sale | 47,668 | $286K | Jun 24 | -24.9% | SEC ↗ |
Mashal RobertFirst filing | Director | Purchase | 25,000 | $118K | Jun 12 | -1.4% | SEC ↗ |
| CHIEF REGULATORY OFFICER | Sale | 36,750 | $184K | Apr 21 | -5.1% | SEC ↗ | |
Liu DongfangFirst in 5 months | CHIEF MEDICAL OFFICER | Sale | 50,000 | $251K | Apr 21 | -5.1% | SEC ↗ |
Wentworth KerryFirst filing | CHIEF REGULATORY OFFICER | Sale | 200,000 | $904K | Apr 8 | +7.1% | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 150,000 | $1.2M | Dec 3 | -42.1% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 10,000 | $75K | Nov 26 | -39.5% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 10,000 | $80K | Nov 26 | — | SEC ↗ | |
| CHIEF SCIENTIFIC OFFICER | Sale | 369,051 | $2.7M | Nov 24 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 20,000 | $140K | Nov 24 | — | SEC ↗ | |
Hanley David C.First filing | CHIEF TECHNICAL OPERATIONS | Sale | 200,000 | $1.4M | Nov 21 | — | SEC ↗ |
Liu DongfangFirst filing | CHIEF MEDICAL OFFICER | Sale | 15,000 | $71K | Nov 19 | — | SEC ↗ |
Liu DongfangFirst filing | CHIEF MEDICAL OFFICER | Sale | 15,000 | $77K | Nov 19 | — | SEC ↗ |
Hattersley GaryFirst filing | CHIEF SCIENTIFIC OFFICER | Sale | 100,000 | $502K | Oct 29 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does NUVB have?
Nuvation Bio Inc. (NUVB) has 17 SEC Form 4 filings (40 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Aug 21, 2026.
When was the most recent SEC Form 4 filing for NUVB?
The most recent Form 4 filing for NUVB on Tracefour is dated Aug 21, 2026.
Who is the most active insider at NUVB?
The most active SEC Form 4 filer at NUVB in the rolling window is CHIEF MEDICAL OFFICER Liu Dongfang, with 7 filings.
What is the net insider flow at NUVB over the last 6 months?
Over the trailing 180 days, insiders at NUVB have net sold $3.3M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NUVB in the current window?
Inside the rolling window, insiders at NUVB bought $118K and sold $9.7M based on SEC Form 4 filings.
Can I get alerts for NUVB insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Nuvation Bio Inc. (NUVB). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Nuvation Bio Inc. is in the Healthcare sector.